The authors highlighted that human umbilical cord-MSC-derived exosomes (hUC-MSC-EXOs) miR-486-5p inhibited glycolysis and cell stemness in colorectal cancer (CRC) by targeting NEK2. They offer compelling evidence supporting the potential application of hUC-MSC-EXOs in the treatment of CRC.
[BMC Cancer]
